SEC Form 4 · accession 0001209191-17-015221
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gina Consylman
Officer — Chief Accounting Officer
Period of report
Feb 24, 2017
Accepted (ET)
Feb 28, 2017 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Feb 24, 2017 | S | 2,962 | $16.53 | D | 26,822 | D | |
| Class A Common Stock | Feb 27, 2017 | A | 26,250 | $0.00 | A | 53,072 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.